ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676581 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676581; 2) Community: the network communities that were significantly associated with the response to NSC 676581; 3) Molecule: the relationships between components within communities and NSC 676581; 4) MDR: the compounds that were significantly associated with the NSC 676581.

NSC Compound Enrichment Correlation
NSC 736153 Null 0.0123744972338278 0.31529356
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0123744972338278 0.25866942
NSC 745813 Null 0.0123744972338278 0.43485704
NSC 107658 CYTOCHALASIN B 0.0123744972338279 -0.057743447
NSC 278632 Null 0.0123744972338279 0.080942594
NSC 603555 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-phenoxy phenyl)-, hydrochloride 0.0123744972338279 0.13299824
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0123744972338279 0.15685508
NSC 624153 Null 0.0123744972338279 0.13698776
NSC 624172 Null 0.0123744972338279 0.15070944
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0123744972338279 0.25100945
Total:96  Current:34    [First] [Prev] [Next] [Last]